Using mechanical forces to improve cancer cell therapies
Synthetic Mechano-Transduction For Improved Cell Therapies In Immuno-Oncology
This study is exploring how using mechanical forces can make CAR T-cell therapies work better for fighting cancer, especially in solid tumors, so that patients can have safer and more effective treatment options.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-11056583 on NIH RePORTER |
What this research studies
This research investigates how mechanical forces can enhance the effectiveness of CAR T-cell therapies, which are designed to target and destroy cancer cells. By engineering T-cells with special sensors that respond to these forces, the researchers aim to improve the specificity and safety of these therapies, particularly for solid tumors. The project involves measuring forces on immune receptors and developing new tools to enhance T-cell activation and function. Patients may benefit from more effective and safer cancer treatments as a result of this innovative approach.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with solid tumors who may benefit from advanced CAR T-cell therapies.
Not a fit: Patients with hematologic malignancies may not receive direct benefits from this research, as it focuses on solid tumors.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer cancer therapies for patients with solid tumors.
How similar studies have performed: While the use of mechanical forces in immunotherapy is a novel approach, similar strategies have shown promise in enhancing cellular therapies in preliminary studies.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Berro, Julien — Yale University
- Study coordinator: Berro, Julien
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.